A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
מצבים רפואיים
Ovarian Neoplasms · Endometrial Neoplasms · Uterine Cervical Neoplasms · Carcinoma, Non-Small-Cell Lung · Triple Negative Breast Neoplasms · Pancreatic Neoplasm · Colorectal Neoplasms
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
HonorHealth, Scottsdale, Arizona, United States
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla, California, United States
South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan, United States
NYU Langone Health - Long Island, Mineola, New York, United States
New York University (NYU) Clinical Cancer Center, New York, New York, United States
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States
The Ohio State University (OSU) Wexner Medical Center, Columbus, Ohio, United States
The University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
START Mountain Region, West Valley City, Utah, United States
Cancer Research SA, Adelaide, Australia
Icon Cancer Centre South Brisbane, QLD, Australia
Centre Leon Berard, Lyon, France
Institut de Cancerologie de l'Ouest - site St-Herblain, Saint-Herblain, France
Oncopole Claudius Regaud, Toulouse, France
Humanitas San Pio X, Milan, Italy
Istituto Europeo di Oncologia, Milan, Italy
Shizuoka Cancer Center, Shizuoka, Japan
National Cancer Center Hospital, Tokyo, Japan
Cancer Institute Hospital of JFCR, Tokyo, Japan
National Cancer Center, Goyang-si Gyeonggi-do, South Korea
Hospital Universitario Vall d'Hebron, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
מובילי המחקר
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company